BANK OF AMERICA CORP /DE/
BankPosition in CRVS — Corvus Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in CRVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,321,501
+$7,854,134 QoQ
Shares Held
757,798
+219.7% QoQ
Ownership
0.901%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 172 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CRVS ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CRVS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,321,501 | 757,798 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,467,367 | 237,004 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,821,010 | 236,495 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $530,916 | 132,729 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $313,385 | 98,549 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $518,848 | 96,981 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,159 | 409 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $713 | 392 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $38 | 22 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,631 | 3,172 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,630 | 5,079 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $58 | 70 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $208 | 254 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $457 | 463 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,508 | 1,530 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,610 | 2,328 | Shares | Defined | 2022-02-08 | |
| 2021-03-31 | $30,602 | 9,936 | Shares | Defined | 2021-05-14 | |
| 2020-03-31 | $7,636 | 3,619 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||